Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 34: 193-204, 2008. First published May 13, 2008; doi:10.1152/physiolgenomics.00220.2007
1094-8341/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
34/2/193    most recent
00220.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Rampon, C.
Right arrow Articles by Huber, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rampon, C.
Right arrow Articles by Huber, P.
Received 18 September 2007; accepted in final form 6 May 2008.
Physiological Genomics 34:193-204 (2008)
1094-8341/08 $8.00 © 2008 American Physiological Society

Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta

Christine Rampon1, Stéphanie Bouillot1, Adriana Climescu-Haulica2, Marie-Hélène Prandini1, Francine Cand1, Yves Vandenbrouck2 and Philippe Huber1

1 Laboratory of Vascular Pathophysiology, Institut National de la Santé et de la Recherche Médicale U882, Commissariat à l'Énergie Atomique (CEA), Grenoble University, CEA, Grenoble, France
2 Laboratory of Informatics and Mathematics for Biology, CEA, Grenoble, France

Protocadherins are transmembrane proteins exhibiting homophilic adhesive activities through their extracellular domain. Protocadherin 12 (Pcdh12) is expressed in angiogenic endothelial cells, mesangial cells of kidney glomeruli, and glycogen cells of the mouse placenta. To get insight into the role of this protein in vivo, we analyzed PCDH12-deficient mice and investigated their placental phenotype. The mice were alive and fertile; however, placental and embryonic sizes were reduced compared with wild-type mice. We observed defects in placental layer segregation and a decreased vascularization of the labyrinth associated with a reduction in cell density in this layer. To understand the molecular events responsible for the phenotypic alterations observed in Pcdh12–/– placentas, we analyzed the expression profile of embryonic day 12.5 mutant placentas compared with wild-type placentas, using pangenomic chips: 2,289 genes exhibited statistically significant changes in expressed levels due to loss of PCDH12. Functional grouping of modified genes was obtained by GoMiner software. Gene clusters that contained most of the differentially expressed genes were those involved in tissue morphogenesis and development, angiogenesis, cell-matrix adhesion and migration, immune response, and chromatin remodeling. Our data show that loss of PCDH12 leads to morphological alterations of the placenta and to notable changes in its gene expression profile. Specific genes emerging from the microarray screen support the biological modifications observed in PCDH12-deficient placentas.

knockout mice; gene profiling; trophoblasts; angiogenesis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.